Paternal preconception exposure to non‐steroid anti‐inflammatory drugs or opioids and adverse birth outcomes: A nationwide registry‐based cohort study
Andrology · 2025
DOI: 10.1111/andr.13551 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Andrology, 2025. Verfasst von Ken Lund und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Paternal Exposure, Registries, Analgesics, Opioid, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Research Council at Odense University Hospital.
Abstract (Originalsprache)
Background and aim Paternal use of analgesics during the time of conception and adverse birth outcomes are poorly studied. We investigated the association between paternal exposure to non‐steroid anti‐inflammatory drugs and opioids within 3 months before the date of conception and the risk of adverse birth outcomes (preterm birth, small for gestational age, low Apgar score, and major congenital malformations).
Methods
We used nationwide data from the Danish health registers. We included information on all singleton live births, and their fathers and mothers from 1997 to 2018. We created two exposed cohorts, children with preconception paternal exposure to (1) non‐steroid anti‐inflammatory drugs and (2) opioids. The unexposed cohort was children without preconception paternal exposure to non‐steroid anti‐inflammatory drugs or opioids, and we performed a sub‐analysis against paternal use of acetaminophen (paracetamol). We used logistic regression models to estimate the odds ratios of adverse birth outcomes including 95% confidence intervals.
Results
We identified 1,260,934 children, 45,667 children with paternal exposure to non‐steroid anti‐inflammatory drugs, 10,086 children with paternal exposure to opioids, and 1,205,181 unexposed children. The adjusted odds ratio for preterm birth was 1.08 (95% confidence interval, 1.03–1.13) after paternal exposure to non‐steroid anti‐inflammatory drugs and 1.21 (95% confidence interval, 1.08–1.35) after paternal exposure to opioids. The adjusted odds ratio for small for gestational age was 1.09 (95% confidence interval, 1.03–1.17) after paternal exposure to non‐steroid anti‐inflammatory drugs, and 1.03 (95% confidence interval, 0.88–1.21) after paternal exposure to opioids. We found null‐associations for a low Apgar score and major congenital malformations. Estimates were attenuated when compared against paternal paracetamol exposure.
Conclusions
Overall, we found null‐associations across the comparisons made. Weak associations were found for paternal exposure to non‐steroid anti‐inflammatory drugs or opioids and preterm birth and small for gestational age, but not with low Apgar score or major congenital malformation. All associations were attenuated when compared against an active comparator of paternal paracetamol exposure. The effect sizes were small and less likely to be of clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark.
- Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
- Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.
- Research Unit of Clinical Pharmacology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Ken Lund, Olav Sivertsen Garvik, Signe Marie Aagaard, Line Riis Jølving, Michael Due Larsen, Per Damkier, Bente Mertz Nørgård
Förderung
- Research Council at Odense University Hospital
Zitieren
APA
Lund, K., Garvik, O. S., Aagaard, S. M., Jølving, L. R., Larsen, M. D., Damkier, P., & Nørgård, B. M. (2025). Paternal preconception exposure to non‐steroid anti‐inflammatory drugs or opioids and adverse birth outcomes: A nationwide registry‐based cohort study. Andrology. https://doi.org/10.1111/andr.13551
Vancouver
Lund K, Garvik OS, Aagaard SM, Jølving LR, Larsen MD, Damkier P, et al. Paternal preconception exposure to non‐steroid anti‐inflammatory drugs or opioids and adverse birth outcomes: A nationwide registry‐based cohort study. Andrology. 2025. doi:10.1111/andr.13551
BibTeX
@article{Lund2025,
author = {Lund, Ken and Garvik, Olav Sivertsen and Aagaard, Signe Marie and Jølving, Line Riis and Larsen, Michael Due and Damkier, Per and Nørgård, Bente Mertz},
title = {Paternal preconception exposure to non‐steroid anti‐inflammatory drugs or opioids and adverse birth outcomes: A nationwide registry‐based cohort study},
journal = {Andrology},
year = {2025},
doi = {10.1111/andr.13551}
}
EUVIMED